Posts by Raymond J. March
Raymond J. March is a Research Fellow and Director of FDAReview.org with the Independent Institute. He is also an Assistant Professor of Economics at Angelo State University where he is the Assistant Director of the Free Market Institute, Assistant Research Professor at Texas Tech University, Public Choice and Public Policy fellow with the American Institute for Economic Research, and an affiliated scholar with the Challey Institute for Global Innovation and Growth. His research has appeared in Health Economics, Southern Economic Journal, Public Choice, Research Policy, Food Policy, Journal of Institutional Economics, The Independent Review and other academic outlets. His popular articles have appeared in Fortune, Washington Examiner, National Interest, Washington Times, Sun Sentinel, The Hill, Real Clear Health, Medical News Daily. He earned his Ph.D. from Texas Tech University.
Economic Miscalculation and the Covid-19 Pandemic
FDA Approves Blood Plasma as Covid-19 Treatment
Promising Alzheimer’s Drug on FDA Fast Track
Is the Covid-19 Pandemic Spreading Affinity for Socialism? It Shouldn’t!
Trump Signs More Executive Orders as a Last-Ditch Effort to Lower Drug Prices
State Mismanagement of Covid-19 Data Continues
Don’t Trust Government to Distribute Covid-19 Drugs
President Trump’s ‘Operation Warp Speed’ Vaccine Project Might Crash Into Perverse Incentives
To Make Drugs More Affordable, President Trump Should Focus on Price Competition
Are Special Interests Undermining the Quest for a Covid-19 Vaccine?
Coronavirus Corruption: Bad Incentives and Politics as Usual
Keep Government Out of Developing a COVID-19 Vaccine
More Executive Orders Will Not Fix Healthcare
Private Enterprise Continues to Flatten the Curve
Economic Prosperity or Pandemic Protection: Why Not Both?
Cut Regulations and Get COVID-19 Drugs to Patients
Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus
To Battle Covid-19, Cut Regulation!
Favor Local Action to Combat the Coronavirus
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Who Should Regulate Tobacco Products? Less Is More!
FDA Expands Ecstasy Access to Veterans with PTSD
Politicians Still Misunderstand High Insulin Prices
Are More Vaping Bans Coming Soon? Let’s Hope Not!

  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org